Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Publication date: Available online 30 March 2020Source: The Lancet HIVAuthor(s): Kelly E Dooley, Radojkam Savic, Akshay Gupte, Mark A Marzinke, Nan Zhang, Vinodh A Edward, Lisa Wolf, Modulakgotla Sebe, Morongwe Likoti, Mark J Fyvie, Innocent Shibambo, Trevor Beattie, Richard E Chaisson, Gavin J Churchyard, DOLPHIN Study Team
Source: The Lancet HIV - Category: Infectious Diseases Source Type: research